Sandoz Group AG (SWX:SDZ)
66.74
+0.68 (1.03%)
Sep 11, 2026, 5:30 PM CET
Sandoz Group AG Employees
Sandoz Group AG had 20,000 employees as of June 30, 2026. The number of employees decreased by 2,356 or -10.54% since the number was reported on December 31, 2025.
Employees
20,000
Change
-2,356
Growth
-10.54%
Revenue / Employee
471.71K CHF
Profits / Employee
26.10K CHF
Market Cap
28.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 20,000 | -2,356 | -10.54% |
| Dec 31, 2025 | 22,356 | 307 | 1.39% |
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,582 |
| Galderma Group AG | 7,676 |
| Galenica AG | 6,623 |
Sandoz Group AG News
- 3 days ago - GRFS or SDZNY: Which Is the Better Value Stock Right Now? - Nasdaq
- 3 days ago - 'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat - CNBC
- 3 days ago - Sandoz Group AG Transcript: CMD 2026 - Transcripts
- 3 days ago - Sandoz Group AG Press release: FY 2026 - Filings
- 3 days ago - Sandoz Group AG Slides: FY 2026 - Filings
- 3 days ago - Sandoz To Invest New Biosimilar Facility In Slovenia - Nasdaq
- 3 days ago - Sandoz Issues Mid-term Outlook For 2025-2030; Unveils Bio100 Ambition - Nasdaq
- 3 days ago - Switzerland's Sandoz pivots to biosimilars, expects rapid mid-term growth - Reuters